↓ Skip to main content

Treatment with echinocandins during continuous renal replacement therapy

Overview of attention for article published in Critical Care, March 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
42 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatment with echinocandins during continuous renal replacement therapy
Published in
Critical Care, March 2014
DOI 10.1186/cc13803
Pubmed ID
Authors

Francisco Javier González de Molina, MariadeLosÁngeles Martínez-Alberici, Ricard Ferrer

Abstract

Echinocandins are indicated as first-line treatment for invasive candidiasis in moderate to severe illness. As sepsis is the main cause of acute kidney injury, the combination of echinocandin treatment and continuous renal replacement therapy (CRRT) is common. Optimizing antibiotic dosage in critically ill patients receiving CRRT is challenging. The pharmacokinetics of echinocandins have been studied under various clinical conditions; however, data for CRRT patients are scarce. Classically, drugs like echinocandins with high protein binding and predominantly non-renal elimination are not removed by CRRT, indicating that no dosage adjustment is required. However, recent studies report different proportions of echinocandins lost by filter adsorption. Nevertheless, the clinical significance of these findings remains unclear.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Italy 1 2%
Unknown 40 95%

Demographic breakdown

Readers by professional status Count As %
Other 8 19%
Researcher 8 19%
Student > Ph. D. Student 6 14%
Student > Doctoral Student 4 10%
Student > Postgraduate 4 10%
Other 5 12%
Unknown 7 17%
Readers by discipline Count As %
Medicine and Dentistry 26 62%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Immunology and Microbiology 1 2%
Psychology 1 2%
Unknown 11 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 April 2014.
All research outputs
#8,185,440
of 25,371,288 outputs
Outputs from Critical Care
#4,291
of 6,554 outputs
Outputs of similar age
#75,504
of 238,323 outputs
Outputs of similar age from Critical Care
#74
of 157 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 6,554 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.8. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 238,323 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 157 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.